Related Experiment Video

Updated: Apr 28, 2026

Basophil Activation Test for Allergy Diagnosis
07:22

Basophil Activation Test for Allergy Diagnosis

Published on: May 31, 2021

9.9K

Evaluating Basophil Histamine Content as a Biomarker for Omalizumab Responsiveness in Chronic Spontaneous Urticaria

Ditte Georgina Zhang1, Katrine Baumann2, Clive Grattan3

  • 1Department of Dermato-Venereology & Wound Healing Centre, Bispebjerg Hospital, Copenhagen, Denmark.

Clinical and Experimental Allergy : Journal of the British Society for Allergy and Clinical Immunology
|April 27, 2026
PubMed
Abstract

No abstract available in PubMed .

More Related Videos

Humanized Mediator Release Assay as a Read-Out for Allergen Potency
10:22

Humanized Mediator Release Assay as a Read-Out for Allergen Potency

Published on: June 29, 2021

4.9K
Basophil Activation Test for Investigation of IgE-Mediated Mechanisms in Drug Hypersensitivity
10:22

Basophil Activation Test for Investigation of IgE-Mediated Mechanisms in Drug Hypersensitivity

Published on: September 16, 2011

35.1K

Related Experiment Videos

Last Updated: Apr 28, 2026

Basophil Activation Test for Allergy Diagnosis
07:22

Basophil Activation Test for Allergy Diagnosis

Published on: May 31, 2021

9.9K
Humanized Mediator Release Assay as a Read-Out for Allergen Potency
10:22

Humanized Mediator Release Assay as a Read-Out for Allergen Potency

Published on: June 29, 2021

4.9K
Basophil Activation Test for Investigation of IgE-Mediated Mechanisms in Drug Hypersensitivity
10:22

Basophil Activation Test for Investigation of IgE-Mediated Mechanisms in Drug Hypersensitivity

Published on: September 16, 2011

35.1K

Related Concept Videos

Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs01:25

Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs

2.3K
Asthma is a chronic respiratory condition for which new therapeutic avenues, including anti-inflammatory drugs like mast cell stabilizers and anti-IgE treatments, continue to be developed.
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
2.3K
Allergic Reactions: Anaphylaxis01:30

Allergic Reactions: Anaphylaxis

277
Anaphylaxis is a severe, life-threatening hypersensitivity reaction mediated by Immunoglobulin E (IgE) antibodies. When IgE binds to allergens, it triggers the release of mediators– histamine, leukotrienes, and prostaglandins from mast cells and basophils. These mediators cause vasodilation, edema, and inflammation, leading to various symptoms.The primary allergens causing anaphylaxis include food items (e.g., peanuts, shellfish), drugs (e.g., penicillin, asparaginase, corticotropin,...
277
Allergic Reactions02:06

Allergic Reactions

26.3K
Overview
26.3K

Articles linked to this work by shared authors, journal, and citation graph.

Management of chronic urticaria: Current status and future prospect.

Journal of the European Academy of Dermatology and Venereology : JEADV·2026

Serological biomarkers of extracellular matrix proteins are associated with hidradenitis suppurativa disease severity and treatment response.

Skin health and disease·2026

Safety and pharmacokinetics of anumigilimab for hidradenitis suppurativa or palmoplantar pustulosis: A phase 1b study.

Journal of the European Academy of Dermatology and Venereology : JEADV·2026

Clinical and mechanistic effects of GLP-1 receptor agonists in hidradenitis suppurativa and comorbidities.

Science progress·2026

Preterm birth is associated with reduced risk of atopic dermatitis and a distinct allergic comorbidity profile in early childhood.

The British journal of dermatology·2026

The Overall Burden of Chronic Spontaneous Urticaria - The Current Landscape.

The British journal of dermatology·2026

High Specificity of sIgE to α-/β-Gliadin and Limited Reactivity to Non-Gluten Proteins in Wheat Allergy Dependent on Augmentation Factors (WALDA).

Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology·2026

Long Non-Coding RNA, Like NEAT1 and MALAT1, in Asthma: Mechanisms and Therapeutic Potential.

Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology·2026

Subcutaneous Allergen Immunotherapy With Thermosensitive Hydrogel and Recombinant Birch Pollen Allergen Variant, a Randomised Controlled Trial.

Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology·2026

Processionary Moth Exposure in Europe: Toxic-Irritant and Immunoglobulin E-Mediated Endotypes, Diagnosis and Management.

Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology·2026

The National Allergy Centre of Excellence-Addressing Australia's Allergy Burden.

Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology·2026

Inflammatory Mediators Associated With Corticosteroid Responsiveness During Asthma Attacks.

Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology·2026

Recurrent kimura disease of unilateral parotid gland: the magnetic resonance imaging findings.

BMJ case reports·2026

Graft IL-33/ST2 signaling promotes cardiac allograft vasculopathy by modulating cardiac resident cell function.

Journal of molecular and cellular cardiology·2026

Contact hypersensitivity promotes hair regeneration through SPP1-secreting macrophages.

The Journal of investigative dermatology·2026

Papain reproduces the prothrombin-dependent PAR1/PAR4 signalling mechanism of the house dust mite allergen Der p 1.

Molecular immunology·2026

A bioinformatic single-cell and structure-informed framework identifies a baicalin-CA2-keratinocyte state axis in atopic dermatitis.

PloS one·2026

Infantile Maculopapular Cutaneous Mastocytosis: A Case Report with an Integrative Unani Medicine Perspective.

Advances in mind-body medicine·2026
See all related articles
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies
Jove
Visualize
Contact Us